Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole as an Adjunct to FSH in IVF
NCT02912988Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Mar 2018
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in infertility (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Live birth rate at 1 year. Started Mar 2018; status: completed.
02
Drugs
letrozole
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02912988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912988.